Unicycive Therapeutics CEO to present at H.C. Wainwright conference
Unicycive Therapeutics said Shalabh Gupta, M.D., the company’s CEO, will present at the H.C. Wainwright 28th Annual Global Investment Conference.
LOS ALTOS, Calif., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc.
NASDAQ:UNCY, a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will presen…